IN8bio (INAB)
(Delayed Data from NSDQ)
$0.31 USD
-0.01 (-2.12%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $0.32 +0.01 (1.81%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMDetailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | -0.13 |
EPS Last Quarter | -0.19 |
Last EPS Surprise | -18.75% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.62 |
Next Year | -0.60 |
EPS (TTM) | -0.83 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.13 | -0.13 | -0.62 | -0.60 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | -0.11 | -0.12 | -0.58 | -0.51 |
High Estimate | -0.11 | -0.12 | -0.58 | -0.51 |
Low Estimate | -0.14 | -0.13 | -0.65 | -0.68 |
Year ago EPS | -0.23 | -0.21 | -1.00 | -0.62 |
Year over Year Growth Est. | 43.48% | 38.10% | 38.00% | 3.23% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.13 | -0.13 | -0.62 | -0.60 |
7 Days Ago | -0.13 | -0.13 | -0.62 | -0.60 |
30 Days Ago | -0.13 | -0.13 | -0.62 | -0.60 |
60 Days Ago | -0.13 | -0.13 | -0.60 | -0.57 |
90 Days Ago | -0.13 | -0.13 | -0.60 | -0.57 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.13 | -0.13 | -0.62 | -0.60 |
Zacks Consensus Estimate | -0.13 | -0.13 | -0.62 | -0.60 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.19 | -0.20 | -0.21 | -0.23 | NA |
Estimate | -0.16 | -0.17 | -0.16 | -0.25 | NA |
Difference | -0.03 | -0.03 | -0.05 | 0.02 | -0.02 |
Surprise | -18.75% | -17.65% | -31.25% | 8.00% | -14.91% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more